ABCG2 and ovarian carcinoma: Taken together, our results suggested that Hsp90 enhanced the expression of ABC transporters in favor of drug efflux and upregulated anti-apoptosis proteins against drug-induced apoptosis, resulting in the MDR of ovarian cancer.